Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E M Griffiths

Showing results (301-310 of 337) with videos related to

Pageof 34
Sort By:
The Journal of Allergy and Clinical Immunology|May 14, 2022
Single-cell analysis implicates T<sub>H</sub>17-to-T<sub>H</sub>2 cell plasticity in the pathogenesis of palmoplantar pustulosisDaniel McCluskey, Natashia Benzian-Olsson, Satveer K Mahil, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
The Journal of Investigative Dermatology|July 24, 2015
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis VulgarisDorottya M Berki, Lu Liu, Siew-Eng Choon, et al.
Nature Communications|December 17, 2021
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
Nature Communications|August 7, 2021
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
The British Journal of Dermatology|September 29, 2025
Grand challenges for skin health revisited: the International League of Dermatological Societies skin disease atlasesSuzanne H Keddie, Christopher E M Griffiths, Gregor B E Jemec, et al.
Nature Reviews. Drug Discovery|March 29, 2013
Challenges and approaches for the development of safer immunomodulatory biologicsJean G Sathish, Swaminathan Sethu, Marie-Christine Bielsky, et al.
The Journal of Investigative Dermatology|September 29, 2022
Damaging Alleles Affecting Multiple CARD14 Domains Are Associated with Palmoplantar PustulosisAthanasios Niaouris, Ariana Hernández-Cordero, Salma Haddad, et al.
Pharmacogenomics|June 23, 2011
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET studyWilliam G Newman, Katherine Payne, Karen Tricker, et al.
Cancer Discovery|October 14, 2025
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β AxisCharles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, et al.
Pageof 34

Showing results (301-310 of 337) with videos related to

Sort By:
Pageof 34
The Journal of Allergy and Clinical Immunology|May 14, 2022
Single-cell analysis implicates T<sub>H</sub>17-to-T<sub>H</sub>2 cell plasticity in the pathogenesis of palmoplantar pustulosisDaniel McCluskey, Natashia Benzian-Olsson, Satveer K Mahil, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
The Journal of Investigative Dermatology|July 24, 2015
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis VulgarisDorottya M Berki, Lu Liu, Siew-Eng Choon, et al.
Nature Communications|December 17, 2021
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
Nature Communications|August 7, 2021
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
The British Journal of Dermatology|September 29, 2025
Grand challenges for skin health revisited: the International League of Dermatological Societies skin disease atlasesSuzanne H Keddie, Christopher E M Griffiths, Gregor B E Jemec, et al.
Nature Reviews. Drug Discovery|March 29, 2013
Challenges and approaches for the development of safer immunomodulatory biologicsJean G Sathish, Swaminathan Sethu, Marie-Christine Bielsky, et al.
The Journal of Investigative Dermatology|September 29, 2022
Damaging Alleles Affecting Multiple CARD14 Domains Are Associated with Palmoplantar PustulosisAthanasios Niaouris, Ariana Hernández-Cordero, Salma Haddad, et al.
Pharmacogenomics|June 23, 2011
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET studyWilliam G Newman, Katherine Payne, Karen Tricker, et al.
Cancer Discovery|October 14, 2025
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β AxisCharles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, et al.
Pageof 34